Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Parathyroid hormone administration may modulate periodontal tissue levels of interleukin-6, matrix metalloproteinase-2 and matrix metalloproteinase-9 in experimental periodontitis

Full text
Author(s):
Marques, M. R. [1] ; dos Santos, M. C. L. G. [1] ; da Silva, A. F. [1] ; Nociti, Jr., F. H. [2] ; Barros, S. P. [3]
Total Authors: 5
Affiliation:
[1] Univ Estadual Campinas, Div Histol, Sch Dent Piracicaba, Dept Morphol, Sao Paulo - Brazil
[2] Univ Estadual Campinas, Sch Dent Piracicaba, Dept Prosthodont Periodont, Div Periodont, Sao Paulo - Brazil
[3] Univ N Carolina, Dept Periodontol, Sch Dent, Chapel Hill, NC 27599 - USA
Total Affiliations: 3
Document type: Journal article
Source: JOURNAL OF PERIODONTAL RESEARCH; v. 44, n. 6, p. 744-750, DEC 2009.
Web of Science Citations: 5
Abstract

Background and Objective: Intermittent administration of the parathyroid hormone (1-34) has an anabolic effect on bone and it has been shown to reduce alveolar bone loss in experimental periodontitis models. The aim of the present study was to investigate the effect of parathyroid hormone on tissue degradation-related factors in an experimental periodontitis model in rats. Material and Methods: Periodontitis was induced in seventy-six male Wistar rats using ligature around the lower right first molars. The animals were then treated with parathyroid hormone (1-34) (T-group) or vehicle (C-group), three times a week for 15 d (C15, T15) or 30 d (C30, T30). At each experimental time-point, the 19 rats were killed in each group and the gingival tissue around the first lower molar was removed and prepared for the following analyses: mRNA expression of interleukin-1beta, interleukin-6, matrix metalloproteinase (MMP)-2 and MMP-9, and gelatinolytic activity of MMP-2 and MMP-9. Hemimandibles were decalcified, and serial sections were processed and analyzed for interleukin-6 immohistochemistry. Samples were also histochemically stained by tartrate-resistant acid phosphatase (TRAP) to evaluate the number of osteoclasts present. Results: Parathyroid hormone-treated samples showed decreased of levels of mRNA for interleukin-6 in the T30 group (p < 0.01) and of MMP-2 in the T15 and T30 groups (p < 0.05). Zymography assays demonstrated that treatment with parathyroid hormone led to a decrease in MMP-9 activity (p < 0.01). TRAP staining of alveolar bone revealed that osteoclasts were present in higher numbers (p < 0.05) in the groups not treated with parathyroid hormone. Conclusion: These data suggest that intermittent administration of parathyroid hormone can down-regulate the expression of biomarkers responsible for connective tissue breakdown and bone resorption, and potentially affect alveolar bone resorption activity. (AU)